ESTRO 2024 - Abstract Book

S5888

RTT - Service evaluation, quality assurance and risk management

ESTRO 2024

The Radiotherapy Transformation Programme within NHS England, in partnership with the NDRS, ProKnow Technical Oversight Group and tumour clinical specialist groups, have developed an innovative approach to identify, share and improve clinical practice using Quality Improvement Toolkits (QITs). These QITs, consisting of clinical and dosimetry metrics within each tumour group, are exploratory benchmarking exercises to understand current clinical practice in England and support reflective subspecialist discussions within radiotherapy networks to address unwarranted variation and improve radiotherapy quality.

Here we present the developed breast radiotherapy clinical metrics and early results of three of the included metrics.

Material/Methods:

The breast radiotherapy clinical metrics, against which practice was assessed, were produced by a breast cancer clinical specialist group using the RCR consensus statements 2 and NICE guideline 3 , as listed in Table 1.

Metrics 1a, 1b and 5 are measurable currently using the RTDS v5.0. Data informing the dose-fractionation of each treatment episode were extracted from this resource for all female patients with breast cancer (ICD10 code C50 for invasive breast carcinoma and D05 for ductal carcinoma in-situ) receiving external beam radiotherapy in the curative